Perbedaan Merck Tbk. dan Sinergi Multi Lestarindo Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Sinergi Multi Lestarindo Tbk. diperdagangkan di Rp144 (kapitalisasi pasar 298 M, volume 24 jam 13,54 jt). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,7× kapitalisasi pasar Sinergi Multi Lestarindo Tbk., dan Sinergi Multi Lestarindo Tbk. lebih aktif diperdagangkan (13,54 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | SMLE | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 298 M |
Volume | 37,6 rb | 13,54 jt |
Lot | 376 | 135,37 rb |
Perputaran | 144,47 jt | 1,83 M |
Harga Rata-rata | 3.842,23 | 135,02 |
Nilai Transaksi | 144,47 jt | 1,83 M |
Harga Ekuilibrium Indikatif | 3.840 | 144 |
Volume Ekuilibrium Indikatif | 7 | 1,56 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Selengkapnya di halaman SMLE →